Press Releases

LONDON--(BUSINESS WIRE)-- Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibro

PARIS--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), a leading global medical products company, will highlight its latest innovations in critical care at the 2018 European Society of Intensive Care Medicine (ESICM) congress in Paris from Oct. 20-24. The company will also sponsor two symposia to address top issues facing critical care clinicians: reducing IV infusion medication programming errors and i

LONDON--(BUSINESS WIRE)-- The global tumor necrosis factor (TNF) inhibitors market 2019-2023 is expected to post a CAGR of close to 10% during the forecast period, according to the latest market research report by

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase

DUBLIN--(BUSINESS WIRE)-- The "Aurora Kinase B - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Pr

DUBLIN--(BUSINESS WIRE)-- The "Heart Transplant Rejection - Pipeline Review, H1 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. This latest Pharmaceutical and Healthcare disease pipeline guide provides an overview of the Heart Transplant Rejection (Immunology)

EDMONTON, Alberta & NEW YORK--(BUSINESS WIRE)-- Global design firm Stantec today announced it has signed an agreement for the sale of its construction division, MWH Constructors, to funds managed by Oaktree Capital Management, L.P (“Oaktree”). The sale of MWH Constructors is inclusive of MWH Constructors’ UK and US divisions and Slayden Constructors, Inc. MWH Constructors joined Stantec through t

DUBLIN--(BUSINESS WIRE)-- The "Innovations in Bio-based Materials, Algae Biomass Production, and Protein Extraction" report has been added to ResearchAndMarkets.com's offering. This edition of the Industrial Bioprocessing TOE features trends and innovations in manufacturing of bio-bas

MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, Inc., a healthcare company focused on the early detection of cancer, today announced that new data from the Circulating Cell-free Genome Atlas (CCGA) study will be presented by Minetta Liu, MD, Research Chair and Professor, Department of Oncology, Mayo Clinic, in an oral presentation at the European Society for Medical Oncology (ESMO) 2018 Congress taking place Octob

DUBLIN--(BUSINESS WIRE)-- The "Recent Advances in Management of Rare Disease" report has been added to ResearchAndMarkets.com's offering. This Genetic Technology TOE depicts new life sciences trends across rare disease management through gene therapy approaches. The corresponding clin

DUBLIN--(BUSINESS WIRE)-- The "Advancements in E-textiles and Quantum Dots" report has been added to ResearchAndMarkets.com's offering. This Microelectronics TOE profiles developments in E-textiles and quantum dots. Innovations include smart textile for monitoring cardiovascular heal

DUBLIN--(BUSINESS WIRE)-- The "Nicotine Addiction - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Nicotine Addiction - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Nicotine Addiction (Centra

DUBLIN--(BUSINESS WIRE)-- The "Rectal Cancer - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Rectal Cancer - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Rectal Cancer

DUBLIN--(BUSINESS WIRE)-- The "Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under develo

HOLLOMAN AIR FORCE BASE, N.M.--(BUSINESS WIRE)-- The U.S. Air Force, alongside El Paso Electric (EPE) (NYSE:EE), officially celebrate the completion and commercial operation of the Holloman Atlas Solar Array at a ribbon cutting ceremony today. The EPE-owned and operated solar facility, its first built to serve a U.S. military installation, spans 42-acres and is dedicated to serve the Holloman Air Force Base ele